HCI's groundbreaking cancer research occurs in many areas - from the lab bench to the clinic to our community and beyond. Scientists pursuing these bold research ideas are engaged in a lifetime of learning that begins with training as a young student and continues throughout their career. As much as anything, training the next generation of cancer researchers is critical to reducing the heavy burden of a cancer diagnosis.

There are a wide variety of undergraduate, pre- and post-doctoral training opportunities available in the laboratories of Huntsman Cancer Institute members. These training opportunities encompass basic science discovery, clinical investigation and population-based studies. Our goals are to understand cancer from its beginnings, to use this knowledge to create new and better treatments, to implement these strategies to improve outcomes and to learn from our efforts across populations to continually minimize the burdens of cancer.

Trainees flourish in a collaborative and collegial, multidisciplinary research environment under the guidance of experienced mentors. 

Recent News

Press Releases, HCI News

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

Read More

Press Releases, HCI News

Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use.

Read More

Press Releases, HCI News

Persistence Pays Off in Discovery That Could Lead to Improved Treatment and Survivability of Patients with Brain Tumors

Gliomas are the most common type of central nervous system cancer but how these tumors develop is not fully understood. Sheri Holmen, PhD a researcher at Huntsman Cancer Institute (HCI) and professor of surgery at the University of Utah just published the results of her research on gliomas in Cell Reports. The work is focused on a mutated gene that is a critical piece of the puzzle for glioma development, according to Holmen’s work.

Read More

Press Releases, HCI News

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Read More